Additionally, the stark contrast in treatment response and biomarker status, particularly the complete loss of hormone receptor expression (ER/PR) in the breast tumor following neoadjuvant chemotherapy, further supports their biological independence. This evidence concerns the gene ESR1 and breast neoplasm.